Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantaion From HLA Matched Related Donors for Treatment of Older Patients With De Novo or Secondary Acute Myeloid Leukemia in First Complete Remission.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fludarabine (Primary)
- Indications Acute myeloid leukaemia; Graft-versus-host disease
- Focus Therapeutic Use
- 29 Jan 2020 Biomarkers information updated
- 01 Mar 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Sep 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.